Structure-function relationships among ryanodine derivatives - Pyridyl ryanodine definitively separates activation potency from high affinity

被引:16
作者
Bidasee, KR [1 ]
Besch, HR [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
D O I
10.1074/jbc.273.20.12176
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ryanodine derivatives are differentially effective on the two limbs of the ryanodine concentration-effect curve. This study comparing ryanodine, ryanodol, and pyridyl ryanodine and nine C10Oeq esters of them focuses on structure-function relations underlying their differential effectiveness. Ryanodol and pyridyl ryanodine had significantly lower affinities than ryanodine, but their EC50act values (concentration of ryanoid that induces one-half of full efficacy), potencies, and efficacies were not diminished in like fashion. Ryanodine and ryanodol were partial agonists, whereas pyridyl ryanodine was a full agonist, having a diminished deactivation potency. C10Oeq esterifications enhanced affinities and efficacies of the base ryanoids, The C-10-O-eq ester derivatives of ryanodine and pyridyl ryanodine, but not those of ryanodol, lost their capacity to deactivate RyR1s, Thus, affinity differences among ryanoids clearly do not predicate functional differences as regards activation of Ca2+ release channels, The pyrrole carboxylate on the C-3 of ryanodine is dispensable to ryanoid activation of Ca2+ release channels. Ryanodol lacks this ring, but it nevertheless effects substantial activation. Moreover, its C-10-O-eq esters display full efficacy, The increased ability of all the C-10-O-eq derivatives to release Ca2+ from the vesicles strengthens their role in directly impeding deactivation of RyR1, perhaps by interaction with some component within the transmembrane ionic flux pathway.
引用
收藏
页码:12176 / 12186
页数:11
相关论文
共 50 条
  • [1] TOTAL SYNTHESIS OF RYANODOL
    BELANGER, A
    BERNEY, DJF
    BORSCHBERG, HJ
    BROUSSEAU, R
    DOUTHEAU, A
    DURAND, R
    KATAYAMA, H
    LAPALME, R
    LETURC, DM
    LIAO, CC
    MACLACHLAN, FN
    MAFFRAND, JP
    MARAZZA, F
    MARTINO, R
    MOREAU, C
    SAINTLAURENT, L
    SAINTONGE, R
    SOUCY, P
    RUEST, L
    DESLONGCHAMPS, P
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1979, 57 (24): : 3348 - 3354
  • [2] 1H-PYRAZOLE-1-CARBOXAMIDINE HYDROCHLORIDE - AN ATTRACTIVE REAGENT FOR GUANYLATION OF AMINES AND ITS APPLICATION TO PEPTIDE-SYNTHESIS
    BERNATOWICZ, MS
    WU, YL
    MATSUEDA, GR
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (08) : 2497 - 2502
  • [3] BERRIDGE MJ, 1996, RYANODINE RECEPTORS, P119
  • [4] BESCH HR, 1977, CIRCULATION, V56, P128
  • [5] BESCH HR, 1998, BIOPHYS J, V74, P60
  • [6] C-10-O-EQ-N-(4-AZIDO-5-(125)IODO SALICYLOYL)-BETA-ALANYL-BETA ALANYL RYANODINE (AZ-BETA-AR), A NOVEL PHOTO-AFFINITY LIGAND FOR THE RYANODINE BINDING-SITE
    BIDASEE, KR
    BESCH, HR
    KWON, S
    EMMICK, JT
    BESCH, KT
    GERZON, K
    HUMERICKHOUSE, RA
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (01) : 33 - 47
  • [7] ACTIVATION AND DEACTIVATION OF SARCOPLASMIC-RETICULUM CALCIUM-RELEASE CHANNELS - MOLECULAR DISSECTION OF MECHANISMS VIA NOVEL SEMISYNTHETIC RYANOIDS
    BIDASEE, KR
    BESCH, HR
    GERZON, K
    HUMERICKHOUSE, RA
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 149 : 145 - 160
  • [8] BIDASEE KR, 1995, BIOPHYS J, V68, P173
  • [9] BUCK E, 1992, J BIOL CHEM, V267, P23560
  • [10] STRUCTURE AND FUNCTION OF RYANODINE RECEPTORS
    CORONADO, R
    MORRISSETTE, J
    SUKHAREVA, M
    VAUGHAN, DM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06): : C1485 - C1504